Dapoxetine: The First SSRI for Premature Ejaculation Management
| Product dosage: 30mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 10 | $4.02 | $40.16 (0%) | 🛒 Add to cart |
| 20 | $3.01 | $80.33 $60.25 (25%) | 🛒 Add to cart |
| 30 | $2.68 | $120.49 $80.33 (33%) | 🛒 Add to cart |
| 60 | $1.67 | $240.99 $100.41 (58%) | 🛒 Add to cart |
| 90 | $1.45 | $361.48 $130.54 (64%) | 🛒 Add to cart |
| 120 | $1.34 | $481.98 $160.66 (67%) | 🛒 Add to cart |
| 180 | $1.23 | $722.97 $220.91 (69%) | 🛒 Add to cart |
| 270 | $1.08 | $1084.45 $291.20 (73%) | 🛒 Add to cart |
| 360 | $0.95
Best per pill | $1445.94 $341.40 (76%) | 🛒 Add to cart |
| Product dosage: 60mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 10 | $4.52 | $45.19 $45.19 (0%) | 🛒 Add to cart |
| 20 | $3.77 | $90.37 $75.31 (17%) | 🛒 Add to cart |
| 30 | $3.01 | $135.56 $90.37 (33%) | 🛒 Add to cart |
| 60 | $2.01 | $271.11 $120.49 (56%) | 🛒 Add to cart |
| 90 | $1.67 | $406.67 $150.62 (63%) | 🛒 Add to cart |
| 120 | $1.59 | $542.23 $190.78 (65%) | 🛒 Add to cart |
| 180 | $1.45 | $813.34 $261.07 (68%) | 🛒 Add to cart |
| 270 | $1.30 | $1220.01 $351.44 (71%) | 🛒 Add to cart |
| 360 | $1.20
Best per pill | $1626.68 $431.77 (73%) | 🛒 Add to cart |
| Product dosage: 90mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 10 | $5.02 | $50.21 (0%) | 🛒 Add to cart |
| 20 | $4.52 | $100.41 $90.37 (10%) | 🛒 Add to cart |
| 30 | $4.35 | $150.62 $130.54 (13%) | 🛒 Add to cart |
| 60 | $3.68 | $301.24 $220.91 (27%) | 🛒 Add to cart |
| 90 | $3.35 | $451.86 $301.24 (33%) | 🛒 Add to cart |
| 120 | $3.10 | $602.47 $371.53 (38%) | 🛒 Add to cart |
| 180 | $2.79 | $903.71 $502.06 (44%) | 🛒 Add to cart |
| 270 | $2.05 | $1355.57 $552.27 (59%) | 🛒 Add to cart |
| 360 | $1.67
Best per pill | $1807.42 $602.47 (67%) | 🛒 Add to cart |
Synonyms | |||
Similar products
Dapoxetine is a short-acting selective serotonin reuptake inhibitor (SSRI) specifically developed and approved for the on-demand treatment of premature ejaculation (PE) in adult men. Unlike traditional daily SSRIs used off-label, dapoxetine’s unique pharmacokinetic profile allows for rapid absorption and elimination, making it suitable for use approximately 1–3 hours before anticipated sexual activity. It represents a significant advancement in sexual medicine, offering a clinically proven, purpose-built pharmacological option for a condition that affects a substantial portion of the male population. Its efficacy is supported by robust clinical trial data, demonstrating a statistically significant increase in intravaginal ejaculatory latency time (IELT) and improvements in patient-reported outcome measures.
Features
- Pharmacological Class: Selective Serotonin Reuptake Inhibitor (SSRI).
- Mechanism of Action: Potently inhibits the presynaptic serotonin transporter, increasing serotonin activity in the central nervous system, which is believed to exert a delaying effect on ejaculation.
- Dosage Forms: Available in film-coated tablet formulations.
- Available Strengths: Typically 30 mg and 60 mg tablets.
- Rapid Onset: Designed for rapid absorption, with a median time to maximum plasma concentration (Tmax) of approximately 1-2 hours.
- Short Half-Life: Features a short elimination half-life of several hours, minimizing long-term drug accumulation and making it suitable for on-demand, rather than continuous, dosing.
Benefits
- Clinically Proven Efficacy: Significantly increases the time to ejaculation, as measured by stopwatch-recorded IELT, providing a tangible and measurable improvement in sexual performance.
- On-Demand Dosing Regimen: Offers flexibility and control, as it is taken only when needed, aligning treatment with sexual activity and avoiding the commitment of daily medication.
- Improves Control and Satisfaction: Empowers men by enhancing perceived control over ejaculation, which directly translates to increased personal satisfaction and reduced distress related to sexual performance.
- Enhances Partner Satisfaction: By prolonging sexual intercourse, it can contribute to a more mutually satisfying sexual experience for both partners, potentially improving relationship dynamics.
- Purpose-Built for PE: As the first and only SSRI specifically developed and approved for the treatment of premature ejaculation, it addresses the condition with a targeted therapeutic approach.
Common use
Dapoxetine is indicated for the treatment of premature ejaculation (PE) in adult men aged 18 to 64 years. The diagnosis of PE is typically applied to men who have a persistent or recurrent pattern of ejaculation occurring within approximately one minute of vaginal penetration (lifelong PE) or a clinically significant and bothersome reduction in latency time, often to three minutes or less (acquired PE), and an inability to delay ejaculation on all or nearly all vaginal penetrations, which causes negative personal consequences such as distress, bother, frustration, and/or the avoidance of sexual intimacy. It is intended for on-demand use in sexually active men.
Dosage and direction
The recommended starting dose is 30 mg, taken orally as a single dose approximately 1 to 3 hours before anticipated sexual activity. The dose may be increased to 60 mg based on efficacy and tolerability. It is not recommended to take more than one dose within a 24-hour period. The tablet should be swallowed whole with at least a full glass of water, with or without food. However, consistent intake with or without food is advised, as a high-fat meal can increase the drug’s exposure, potentially increasing the incidence and severity of side effects.
Precautions
- Dapoxetine is not indicated for use by women or individuals under 18 years of age.
- It should be used with caution in patients with underlying psychiatric conditions.
- Patients should be monitored for the emergence of serotonin syndrome or neuroleptic malignant syndrome (NMS)-like reactions, especially when used concomitantly with other serotonergic drugs.
- Due to the risk of orthostatic hypotension and syncope, patients should be advised to avoid situations where injury could result should syncope occur (e.g., operating machinery, driving).
- Use with caution in patients with a history of mania or hypomania, as SSRIs may induce these states.
- Caution is advised in patients with bleeding tendencies or those on concomitant medications that affect hemostasis, as SSRIs are associated with an increased risk of bleeding.
- As with other SSRIs, discontinuation symptoms may occur upon abrupt cessation, even with on-demand use over time.
Contraindications
- Hypersensitivity to dapoxetine or any of the excipients in the formulation.
- Concomitant administration with monoamine oxidase inhibitors (MAOIs) or within 14 days of discontinuing treatment with an MAOI due to the risk of serotonin syndrome. Similarly, a 7-day washout period is required after stopping dapoxetine before starting an MAOI.
- Concomitant use with thioridazine or within a month of stopping thioridazine.
- Patients with significant pathological cardiac conditions such as heart failure (NYHA Class II-IV), conduction abnormalities (e.g., sick sinus syndrome, sinoatrial or AV block), significant ischemic heart disease, or significant valvular disease.
- History of syncope.
Possible side effect
The most commonly observed side effects are dose-dependent and are typically mild to moderate in intensity. They often diminish with continued use.
- Very Common (≥1/10): Headache, dizziness, nausea.
- Common (≥1/100 to <1/10): Diarrhea, insomnia, fatigue, somnolence, anxiety, tremors, blurred vision, vomiting, abdominal pain, dry mouth, hyperhidrosis (increased sweating), decreased libido, erectile dysfunction, tension, irritability.
- Uncommon (≥1/1,000 to <1/100): Syncope (fainting), orthostatic hypotension, tachycardia, palpitations, ringing in the ears (tinnitus), attention disturbance, disorientation, euphoric mood, bruising, flushing.
- Rare: Priapism (prolonged and painful erection) has been reported with SSRIs and is a medical emergency requiring immediate treatment.
Drug interaction
Dapoxetine is primarily metabolized by multiple CYP enzymes, including CYP3A4, CYP2D6, and others. It is also a weak CYP2D6 inhibitor.
- Potent CYP3A4 Inhibitors (e.g., ketoconazole, itraconazole, ritonavir, clarithromycin): Concomitant use is contraindicated, as it can lead to a significant increase in dapoxetine exposure.
- Moderate CYP3A4 Inhibitors (e.g., erythromycin, fluconazole, diltiazem): Use with caution; do not exceed the 30 mg dose.
- Potent CYP2D6 Inhibitors (e.g., fluoxetine, paroxetine): Use with caution; do not exceed the 30 mg dose.
- Serotonergic Drugs (e.g., other SSRIs, SNRIs, triptans, tramadol, tryptophan): Increased risk of serotonin syndrome.
- Drugs that Increase Heart Rate/BP or Cause Orthostasis (e.g., alpha-blockers for BPH, nitrates for angina): Potential for additive effects on blood pressure and heart rate.
- Alcohol: Concomitant use with alcohol may increase the risk of adverse events such as dizziness, lightheadedness, and syncope; it may also increase cardiac adverse effects. Patients should be advised to avoid alcohol while taking dapoxetine.
Missed dose
As dapoxetine is taken on an as-needed basis prior to sexual activity, the concept of a “missed dose” in the traditional sense does not apply. If a dose is not taken within the recommended time frame before intercourse, it should simply be omitted. The patient should not take a double dose to make up for the missed timing.
Overdose
In the event of overdose, supportive measures should be instituted. Symptoms of overdose are expected to be primarily related to the increased serotonergic and possible cardiovascular effects of the drug and may include serotonin syndrome (agitation, confusion, diaphoresis, hallucinations, hyperreflexia, myoclonus, shivering, tachycardia), dizziness, nausea, vomiting, and syncope. There is no specific antidote for dapoxetine overdose. Treatment should consist of general supportive measures, including monitoring of vital signs and cardiac function. Due to the drug’s high protein binding and large volume of distribution, forced diuresis, dialysis, hemoperfusion, and exchange transfusion are unlikely to be of benefit.
Storage
Store at room temperature (15°C to 30°C or 59°F to 86°F). Keep the medication in its original container to protect it from light and moisture. Keep out of reach of children and pets. Do not use after the expiration date printed on the packaging.
Disclaimer
This information is for educational and informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any new treatment. Never disregard professional medical advice or delay in seeking it because of something you have read here. The information provided may not cover all possible uses, directions, precautions, drug interactions, or adverse effects.
Reviews
- Clinical Trial Data: Multiple randomized, double-blind, placebo-controlled studies involving thousands of men with PE have consistently demonstrated that dapoxetine 30 mg and 60 mg taken on-demand significantly increased IELT and improved patient-reported outcomes of control, satisfaction, and distress compared to placebo. These studies form the bedrock of its approval and expert recommendation.
- Real-World Evidence: Post-marketing studies and clinical experience suggest that dapoxetine is an effective and well-tolerated option for many men with PE. Patient satisfaction often correlates with proper patient selection, adequate education on its on-demand use and potential side effects, and managing expectations. Many urologists and sexual medicine experts consider it a valuable first-line pharmacological tool in a comprehensive PE management plan that may also include behavioral techniques.
- Critical Analysis: While effective, reviews often note that its benefits must be weighed against its side effect profile, particularly nausea, dizziness, and the small but important risk of syncope. Its cost and availability (as a prescription-only medication) are also factors considered in patient reviews and treatment decisions. It is widely regarded as a significant, though not perfect, advancement in the treatment of a previously underserved condition.